GB201511453D0 - Treatment of alzheimer's disease - Google Patents
Treatment of alzheimer's diseaseInfo
- Publication number
- GB201511453D0 GB201511453D0 GBGB1511453.1A GB201511453A GB201511453D0 GB 201511453 D0 GB201511453 D0 GB 201511453D0 GB 201511453 A GB201511453 A GB 201511453A GB 201511453 D0 GB201511453 D0 GB 201511453D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- alzheimer
- disease
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 208000024827 Alzheimer disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1511453.1A GB201511453D0 (en) | 2015-06-30 | 2015-06-30 | Treatment of alzheimer's disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1511453.1A GB201511453D0 (en) | 2015-06-30 | 2015-06-30 | Treatment of alzheimer's disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201511453D0 true GB201511453D0 (en) | 2015-08-12 |
Family
ID=53872437
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1511453.1A Ceased GB201511453D0 (en) | 2015-06-30 | 2015-06-30 | Treatment of alzheimer's disease |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB201511453D0 (en) |
-
2015
- 2015-06-30 GB GBGB1511453.1A patent/GB201511453D0/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL324723A (en) | Methods for treating alzheimer's disease | |
| IL247085A0 (en) | Methods of treating alzheimer's disease | |
| ZA201605341B (en) | Methods of treating alzheimer's disease | |
| EP3268086A4 (en) | Lsd for the treatment of alzheimer's disease | |
| IL263188B (en) | Treatment for parkinson's disease | |
| PT3458045T (en) | Treatment of meniere's disease | |
| EP3137097C0 (en) | Treatment and prevention of alzheimer's disease (ad) | |
| IL254252A0 (en) | Tetrahydrofurane-fused aminohydrothiazine derivatives which are useful in the treatment of alzheimer's disease | |
| PT3137094T (en) | Treatment and prevention of alzheimer's disease (ad) | |
| PL3137093T3 (en) | Treatment and prevention of alzheimer's disease (ad) | |
| ZA202001588B (en) | Method of treating alzheimer's disease | |
| IL263837A (en) | Treatment of ocular disease | |
| IL257802A (en) | Compositions and methods for the treatment of parkinson's disease | |
| GB201622116D0 (en) | Treatment of liver disease | |
| GB201511453D0 (en) | Treatment of alzheimer's disease | |
| ZA201807944B (en) | Treatment for parkinson's disease | |
| GB201504144D0 (en) | Treatment of Parkinson's disease | |
| GB201621398D0 (en) | Treatment of emt-associated disease | |
| GB201518052D0 (en) | Parkinson's disease treatment | |
| AU2017902309A0 (en) | Treatment of alzheimer's disease | |
| AU2017902307A0 (en) | Treatment of alzheimer's disease | |
| GB201610938D0 (en) | Treatment of ocular disease | |
| GB201614863D0 (en) | Alzheimer's disease | |
| GB201504413D0 (en) | Treatment of disease | |
| GB201414038D0 (en) | Alzheimer's disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |